Company intelligence / Profile preview

Medicardium

Oregon, USA
Ownership
Private
Employees
~10
Development stage
Other
01

Overview

Medicardium is a healthcare company specializing in detoxification and cardiovascular wellness through its proprietary EDTA chelation products. Founded in 2000 and led by inventor Spencer Feldman, the company is best known for its Medicardium suppositories, which utilize a unique Magnesium Di-Potassium EDTA formula designed to remove heavy metals and address soft tissue calcification. Unlike traditional intravenous chelation, Medicardium's suppository-based delivery system offers a non-invasive, at-home alternative that bypasses the digestive tract for improved systemic absorption. The company's product line, marketed under the RemedyLink brand, also includes formulations for liver, kidney, and lymphatic support. Medicardium primarily serves the alternative medicine, holistic health, and chiropractic sectors, focusing on anti-aging and systemic detoxification.

Therapeutic areas
EndocrinologyCardiovascularOtherPsychiatry
Modalities
Small molecule
Industry
Food & Nutrition

Beyond the preview

Go deeper on Medicardium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicardium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call